IT IS OFTEN DESIRED to compare 2 or more methods of treatment for a particular disease, where it is not known in advance which treatment is the more effective. Whether one treatment is new, or whether all are established in practice, the best comparison will be obtained by undertaking a prospective, controlled study (Hill, 1977) . One question which arises early in the planning of such a study is how the patients are to be allocated to the different treatment groups, in order to obtain a meaningful comparison.
There are 2 main considerations when deciding on the method of allocation. The first is that the patients should be allocated to the treatment groups in such a way that scientifically valid conclusions can be drawn at the end of the study, giving the maximum amount of information on the relative merits of the different treatments. Statistical matters will enter into this. The second consideration is that the allocation procedure must be feasible in practice as well as in theory. In general, patients will enter the study one by one, and the treatment for each patient will need to be known soon after entry. Thus the allocation procedure must not be too complex or time-consuming. Indeed a complicated scheme could be counter-productive, in that it might deter busy clinicians from entering patients into the study.
Here we describe schemes which both provide "good" allocations, and have been found to be convenient in practice. No statistical or computational expertise is required for any of the procedures. The analysis of the results of a study is not considered here, as this has been well documented elsewhere (Armitage, 1971; Peto et al., 1976 Peto et al., , 1977 .
Allocation schemes: the need for randomtization
The essential aim of any method of treatment allocation in a clinical study is to allow an efficient statistical comparison of the merits of the treatments to be made at the end of the investigation. We shall discuss the allocation schemes which are most reliable in achieving this end. For the most part we shall restrict our discussion to a study comparing 2 treatments, A and B (say), where approximately equal numbers of patients are to receive each treatment. Not all studies fall into this category. Some aim to compare more than two treatments (e.g. the Medical Research Council investigations in the treatment of rectal cancer (1974) ) and in some studies it is preferable to have more patients in one treatment group than in another (Peto et al., 1976 Subjective and deterministic procedures.-Clinicians are used to choosing themselves the treatment which they consider is best for their patient. Such a decision will be based on their knowledge of the efficacy of the treatment, and the possibility of any unacceptable side effects. The tacit assumption behind a clinical study, however, is that it is not known initially which is the "better" of the 2 treatments for a patient. (If there are individual patients for whom one treatment is preferred, they are not included in the study.)
Nevertheless it is not uncommon to find clinicians who, while having some general preference for one of the treatments, still decide to take part in an investigation. They do this because they recognise that the study will give them an evaluation of the relative merits of the 2 treatments which is more reliable than the information they already possess.
Since a clinician may have a preference for one treatment, it would not be wise to allow him to allocate the treatment by his own choice to each patient. This is because he might, for example, either consciously or unconsciously give the treatment he preferred to those patients with a better prognosis, thus hoping to ensure a good result for this treatment. Even if this is unlikely to happen, it is best to exclude the possibility completely, so that there can be no doubt in the matter at the end of the investigation.
We therefore require an allocation procedure which is not subjective, that is, not dependent on anyone's personal decision. One such method is that of "alternation". We give treatment A to the first patient who enters the study, B to the second, A to the third, and so on. This method has the advantage of being extremely simple to carry out. The very simplicity of the scheme raises a problem, however, since the clinician will be aware of the treatment which is to be allocated to the next patient. He will therefore be in a position to select the patient whom he considers most suitable for that treatment, so that the type of concealed difference mentioned above could possibly arise.
The alternation method is an example of a "deterministic" procedure. Other such procedures are allocation according to the last digit of the hospital number, first letter of surname, or month of birth. These all allow the possibility of concealed differences between the treatment groups, because the treatment allocation can be determined before the decision to enter the patient to the study has been made. In addition, there may well be other forms of bias. For example, there could be a difference in racial characteristics between the groups, if the first letter of surname is used.
Simple and restricted randomization. To avoid the possibility of prediction of the next allocation, a random element is usually introduced into the procedure. The simplest form of randomization is equivalent to tossing a coin, and allocating A or B depending on whether the coin comes down "heads" or "tails". In practice a list of random numbers produced by a computer is used to give a random sequence of As and Bs (Armitage, 1971) . SSuch a sequence is shown in Table I .
In the long run, sequences based on random numbers will lead to approximately equal numbers of As and Bs, but by chance there may sometimes be a large imbalance. From the statistical point of view it is not essential to have exactly equal numbers on the two treatments, but a more efficient comparison will generally be obtained if the numbers are as close as possible (see Appendix). Although serious losses in efficiency are unlikely to occur from a chance imbalance in numbers, it would appear sensible to rule out the possibility.
A modification of the above method is known as "restricted randomization". In this method the numbers of patients allocated to each treatment are forced to 850o (The "balancing number" 6 is at the discretion of the organizer.) Thus if 3 of the first 4 patients have been allocated treatment A, the next 2 patients will necessarily be allocated B, so that after 6 patients have been entered there will be 3 in each treatment group. The same system is used for the next 6 patients, and so on, until the entry of patients is completed. Table I is, in fact, a restricted randomization list with balancing number 8. So that it is more difficult for the investigator controlling entry of patients to predict the next allocation, he should remain unaware of the balancing numnber. Other devices can be introduced to prevent the pattern being detected as the study progresses. One such is to split one of the blocks of 6 (or whatever number is used) into two parts, and to insert one part at another point in the sequence.
A method of producing a restricted randomization list has been described by Peto et al. (1976) . For a balancing number 6, each of the 20 possible sequences of 3 As and 3 Bs is associated with a different set of 2-digit numbers (e.g. AAABBB can be associated with the numbers 00 to 04, AABABB with 05 to 09, and so on). Pairs of digits are then read from a list of random numbers, and the corresponding sequences are written down in order.
Whatever method is used to produce the list of As and Bs, the final sequence must not, of course, be available to the investigator entering patients. If he knows in advance what the allocation for a patient will be, the purpose of the randomization is lost. One procedure is then to make out a card for each allocation. The patient serial number and allocated treatment are written on the card, and the card is sealed in an envelope bearing only the serial number. The envelopes are kept by the clinician in a pack in order of serial number, and the allocation is made by opening the next envelope in the sequence as each patient enters the study.
Another possibility is for an independent person to keep the list of As and Bs, and to tell the clinician the allocation only after he has entered a patient. This means that the procedure can be seen to be completely objective. A further advantage of this method in a multicentre study, where the treatment allocation is obtained by telephoning one main office, is that a central record can be kept of the patients who have been entered. It is then possible to check at a later date that no patient has been lost to the study.
The use of prognostic information
Before a patient starts treatment, we often have certain information which we know or suspect will be related to prognosis. For example, the patient's age, or the stage which the disease has reached before treatment starts may affect the prognosis. We shall refer to such pretreatment items of information as "prognostic variables". In a multicentre study we may wish to see if the results vary between centres, and then "centre" is considered to be a prognostic variable.
When analysing the results of a study, we can use these variables in 3 ways. First we may see if there is any evidence that a variable does relate to prognosis. This may shed light on the disease process or on the mode of action of the treatments. It may also be valuable to the clinician in the future choice of treatment policy, and may be socially useful if it permits a more accurate prediction of the outcome for a patient. Secondly we may allow for any imbalance in the distribution of the important variables across the treatment groups, in our comparison of the treatments. Thirdly we may be able to identify subgroups of patients, in terms of the prognostic variables, who respond to treatment differently from the remainder. This last possibilitv requires a larger number of patients in the study than the other 2.
To achieve these aims it is desirable to have similar numbers of patients who are alike, in terms of the prognostic variables, receiving the 2 treatments. For example, if older patients might respond differently from younger patients, we would prefer to have half of our older patients receiving Treatment A, and half Treatment B. We could then see if, for older patients as distinct from younger, there was some difference in response to treatment. Similarly, if "centre" is a prognostic variable, we shall wish to have similar numbers of patients in a centre receiving each treatment.
Powerful methods of statistical analysis are available to allow for the effects of prognostic factors in the main treatment comparison, and these compensate to a large extent for an unequal treatment allocation (Armitage and Gehan, 1974; Cox, 1972) . However, we shall make best use of the resources if we aim to have equal numbers for the variables which we suspect to be related to prognosis. Usually, loss of precision in the main comparison by omitting to balance for a prognostic factor will be small (see Appendix).
Nevertheless, where important prognostic variables are known to exist, it would seem sensible to opt for the extra precision obtained from balanced numbers, if balance can be achieved simply. It is likely that the gain in precision in the main treatment comparison will be of most importance in studies with <100 patients, where several important prognostic factors exist. Balanced numbers may also be valuable when examining interactions between treatment and prognostic variables, even for larger studies.
We then wish to have an allocation scheme which takes account of each patient's values of the prognostic variables before allocating treatment. In such a scheme, it will generally only be possible to include prognostic variables which are readily available at the time the patient enters the study, since waiting for other assessments to be made could delay treatment. Such information as age, sex and diagnosis can in general be quickly obtained, but it should be remembered that details such as laboratory results may not be immediately available. It may be better not to attempt to balance for a variable, rather than have patients lost to the study because there is no time to find the necessary information.
Stratifed randomnization.-When the prognostic variables to be used in allocation have been chosen, one method which can sometimes be used is to have a separate restricted randomization list for each "stratum" defined by the variables. For example, suppose that there is one prognostic variable, age, with two "levels" (i.e. possible categories): over 65 and 65 or under. A separate randomization sequence is employed for each prognostic stratum, namely one sequence for the patients over 65, and one for those 65 or under (Table II) .
This method of allocation is known as "stratified randomization". As with simple or restricted randomization, the procedure As the number of prognostic variables increases, and especially if those variables have more than 2 levels, the total number of prognostic strata soon increases to an unmanageable size. For example, a study with 4 prognostic variables which have 2, 2, 3 and 4 levels has a total of 2x2x3x4 48 strata. If only 100 patients are to be entered, the numbers of patients in many strata will be too small for the balancing of treatment numbers, so that the method will not operate efficiently.
A new method: minimiization. A numnber of procedures have been suggested to cope with this problem, but they are often too complex to be practical. One method, sometimes known as "minimization", has been developed recently (Taves, 1] 974; Pocock and Simon, 1975; Freedman and W; \hite, 1 976) . It overcomes the difficulties of large numnbers of strata by allowing the investigator to choose to balance the treatment groups in a less complete way than that attempted in stratified randomization. Stratified randomization aims to obtain equal numbers on each treatment for every possible combination of the prognostic variables, whereas the minimization method restricts its aim to equalizing treatment numbers at the different levels of each variable taken separately. In special cases where 2 prognostic variables interact, so that it is their combination which is of interest, the minimization method can be adapted to balance numbers among all combinations of that pair of variables, as well as among the remaining variables separately. Minimization has been shown to be superior to both simple and stratified randomization in producing balance for the separate prognostic variables, for the size of study most often undertaken. It is particularly superior when the number of strata is large in comparison with the number of patients (Pocock and Simon, 1975) .
We shall describe a simple version of the method, and show how it can be made more sophisticated if necessary. The general method is quite complex, and often needs a small computer for its implementation, but the simplified version needs only a few hand additions of numbers.
The method aims to achieve a final distribution of treatments which is bal- Implementation of the method. Fortunately we do not need to do all the cal-X.)3 culations detailed above at every stage, because they can be condensed to a simple procedure. Surprisingly, it turns out in practice to be easier to use as a measure of imbalance not the difference between the numbers in the treatment groups, were a particular treatment to be assigned, but their statistical vcariance. (In the case of 2 treatments this is equivalent to using the square of the difference.) It may not be immediately obvious that the method we describe bears any relation to using the variance measure to minimize imbalance, but it is in fact equivalent (Freedman and White, 1976) . We shall describe the method for a study with a general (unspecified) number m of prognostic variables.
Suppose ... bm and to compare them to see which is the lower. We choose Treatment A for the new patient if the first sum is lower, Treatment B if the second sum is lower.
If the sums are identical, we can choose between A and B using a prepared random sequence of allocations. This sequence can be similar to that described in the section on simple randomization, with each allocation being deleted when it has been used to resolve a tie. An alternative procedure, which can be useful when a sophisticated version of the method is employed, is detailed below. Table III shows the calculations at a particular point in a study comparing 2 In the previous sections, each new method has been presented as a refinement of the one before it. However, this is not meant to imply that the most complex method is necessarily the best one to use in every sit uation.
We recommend that one of 3 methods be used: "restricted" randomization, "stratified" randomization, or "minimization". The choice between the methods for anv study will depend on such factors as the number of patients to be entered, the importance and number of ally known prognostic variables, the ease with which the prognostic information can be obtained at the time of allocation, whether there are one or many centres involved, and the organizational set-up for treatment allocation. The account given in the preceding sections aims to give the background against which an informed choice can be made.
APPENDIX Suppose that w%ith a current method of treatment, only 500 of patients w-ith a certain disease live longer than 5 years. W\e wish to see if there is a significant (P_0 05) difference in survival when a new treatment is used, and are interested in an improvement to (say) 80%.
If we enter 100 patients into our study, and allocate 50 (at random) to each treatment, the statistical power" of the study to 
